SEC 13F Intelligence

Managers / Q3 2022 · view latest →

BERYLSON CAPITAL PARTNERS, LLC

CIK 0001572664 · 200 CLARENDON STREET, 50TH FLOOR, BOSTON, MA, 02116 · 617-697-5815

Reported Value
$61M
Q3 2022
Positions
23
Filings on Record
23
2019–present window
Filed
Nov 14, 2022
original filing

Summary

Berylson Capital Partners, LLC reported $61M in U.S.-listed holdings across 23 positions for Q3 2022.

Its largest position, ASND, represents 8.7% of the portfolio.

Compared with Q2 2022, the fund opened 8 new positions and exited 5.

Portfolio Metrics

Turnover
+24.0%
vs prior filed quarter
Top-10 Concentration
+66.4%
share of reported value
Largest Position
+8.7%
Ascendis Pharma A S
New / Exited
8 / 5
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $85MQ1 ’19Q2 ’19: $56MQ3 ’19: $40MQ4 ’19: $118MQ4 ’19Q1 ’20: $37MQ2 ’20: $163MQ3 ’20: $286MQ3 ’20Q4 ’20: $585MQ1 ’21: $411MQ2 ’21: $451MQ2 ’21Q3 ’21: $216MQ4 ’21: $91MQ1 ’22: $85MQ1 ’22Q2 ’22: $37MQ3 ’22: $61MQ4 ’22: $34MQ4 ’22Q1 ’23: $40MQ2 ’23: $35MQ3 ’23: $39MQ3 ’23Q4 ’23: $54MQ1 ’24: $50MQ2 ’24: $39MQ2 ’24Q3 ’24: $41Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 84.7%ADR: 12.3%Other: 2.9%Equity WRT: 0.1%
  • Common Stock · 84.7% · $51M
  • ADR · 12.3% · $7M
  • Other · 2.9% · $2M
  • Equity WRT · 0.1% · $76,000

Quarter-over-Quarter Changes full breakdown →

vs Q2 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ASNDASCENDIS PHARMA A/SNEW+51.0K51.0K+$5M$5M
FTCHQFARFETCH LTDNEW+393.0K393.0K+$3M$3M
STNESTONECO LTDNEW+298.0K298.0K+$3M$3M
ZZILLOW GROUP INCNEW+85.4K85.4K+$2M$2M
ASANASANA INCNEW+98.0K98.0K+$2M$2M
CONFLUENT INCNEW+65.0K65.0K+$2M$2M
PPLIIAC INCNEW+18.2K18.2K+$1M$1M
FLLFULL HSE RESORTS INCNEW+36.0K36.0K+$202,000$202,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2022

23 positions
#IssuerClass% PortfolioValueShares
1ASNDASCENDIS PHARMA A/Shistory →SPONSORED ADR8.70%$5M51.0K
2WRBYWARBY PARKER INChistory →CL A COM8.42%$5M382.0K
3TOSTTOAST INChistory →CL A7.73%$5M280.0K
4LSPDLIGHTSPEED COMMERCE INChistory →SUB VTG SHS7.42%$4M255.5K
5FLEETCOR TECHNOLOGIES INCCOM7.33%$4M25.2K
6SESEA LTDhistory →SPONSORD ADS6.48%$4M70.0K
7BILIBILIBILI INChistory →SPONS ADR REP Z5.77%$3M228.0K
8ARCHAEA ENERGY INCCOM CL A5.05%$3M169.9K
9FTCHQFARFETCH LTDhistory →ORD SH CL A4.84%$3M393.0K
10STNESTONECO LTDhistory →COM CL A4.69%$3M298.0K
11CARDLYTICS INCCOM4.47%$3M288.0K
12ZZILLOW GROUP INChistory →CL C CAP STK4.04%$2M85.4K
13ASANASANA INChistory →CL A3.60%$2M98.0K
14DKNGDRAFTKINGS INC NEWhistory →COM CL A3.58%$2M143.0K
15ADPTADAPTIVE BIOTECHNOLOGIES CORhistory →COM3.41%$2M289.7K
16CVNACARVANA COhistory →CL A3.06%$2M91.4K
17LAZYDAYS HLDGS INCCOM2.88%$2M129.0K
18CONFLUENT INCCLASS A COM2.55%$2M65.0K
19FSLYFASTLY INChistory →CL A2.38%$1M157.0K
20PPLIIAC INChistory →COM NEW1.67%$1M18.2K
21RIVNRIVIAN AUTOMOTIVE INChistory →COM CL A1.48%$893,00027.1K
22FLLFULL HSE RESORTS INCCOM0.33%$202,00036.0K
23WGSWWSEMA4 HOLDINGS CORPW EXP 07/22/20260.13%$76,000333.3K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2024$41M21Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$39M20Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$50M24May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$54M27Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$39M26Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$35M21Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$40M20May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$34M19Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$61M23Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$37M20Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$85M30May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$91M25Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$216M27Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$451M60Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$411M55May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$585M65Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$286M47Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$163M28Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$37M15May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$118M36Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$40M19Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$56M20Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$85M32May 15, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • BERYLSON JAMES028-18556

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.